Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Survey and Trend Research 2018

September 2018 | 71 pages | ID: G354AC83CA8EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Astellas, Johnson & Johnson, Sanofi, Dendreon. etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CASTRATION-RESISTANT PROSTATE CANCER (CRPC)/HRPCA THERAPEUTICS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Astellas (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Sanofi (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Dendreon. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market 2012-2017, by Type, in USD Million
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast 2018-2023, by Type, in USD Million
Table Astellas Overview List
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business Operation of Astellas (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Sanofi Overview List
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
Table Dendreon. Overview List
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business Operation of Dendreon. (Sales Revenue, Cost, Gross Margin)
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue Share, by Companies, in USD Million
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Demand 2012-2017, by Application, in USD Million
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Demand Forecast 2018-2023, by Application, in USD Million
Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market 2012-2017, by Region, in USD Million
Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry Chain Structure
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Growth 2012-2017, by Type, in USD Million
Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region